Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future

Area of Science:

• Cardiovascular Research
• Immunology
• Inflammation Biology

Background:

• Atherosclerotic cardiovascular disease is a leading cause of global mortality.
• Chronic inflammation of the arterial wall is a key characteristic of this disease.
• Current treatments leave many patients with significant residual cardiovascular risk due to persistent inflammation.

Purpose of the Study:

• To review experimental and clinical evidence for immune-based therapies in cardiovascular disease.
• To specifically evaluate vaccination strategies for reducing cardiovascular risk.
• To identify novel treatment avenues for patients with high residual cardiovascular risk.

Main Methods:

• Literature review of experimental studies on immune modulation in atherosclerosis.
• Analysis of clinical trial data for immune-based cardiovascular interventions.
• Focus on vaccination strategies targeting inflammatory pathways in cardiovascular disease.

Main Results:

• Evidence suggests immune system modulation can control atherosclerotic cardiovascular disease.
• Vaccination strategies show promise in preclinical and clinical settings for cardiovascular risk reduction.
• Inflammation remains a critical target for managing residual cardiovascular risk.

Conclusions:

• Immune-based therapies, including vaccination, represent a promising frontier for managing atherosclerotic cardiovascular disease.
• Targeting inflammation through novel immune strategies is crucial for improving outcomes in high-risk patients.
• Further research into vaccination for cardiovascular disease holds potential for significant clinical impact.